Romosozumab is a medication used to treat bone loss in women after menopause who are at high risk of fractures. It helps to increase bone density and strength, which ultimately reduces the risk of fractures. This medication is typically administered as a subcutaneous injection of 105 mg/1.17 ml once a month. It is best to take this medication at the same time each month to ensure consistent and effective treatment.
71b2
source
